Carolinas Wealth Consulting’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20
Closed -$271 134
2025
Q1
$271 Hold
20
﹤0.01% 997
2024
Q4
$338 Hold
20
﹤0.01% 1036
2024
Q3
$407 Hold
20
﹤0.01% 1018
2024
Q2
$452 Hold
20
﹤0.01% 998
2024
Q1
$525 Hold
20
﹤0.01% 973
2023
Q4
$631 Hold
20
﹤0.01% 888
2023
Q3
$482 Hold
20
﹤0.01% 929
2023
Q2
$738 Hold
20
﹤0.01% 941
2023
Q1
$599 Hold
20
﹤0.01% 973
2022
Q4
$612 Hold
20
﹤0.01% 975
2022
Q3
$0 Hold
20
﹤0.01% 881
2022
Q2
$1K Hold
20
﹤0.01% 798
2022
Q1
$1K Hold
20
﹤0.01% 827
2021
Q4
$1K Buy
+20
New +$623 ﹤0.01% 864

Other funds holding CC

Carolinas Wealth Consulting's CC Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Chemours (CC) in Q2 2025, closing a stake of 20 shares — an estimated $271 sold.

Carolinas Wealth Consulting first reported a position in CC in Q4 2021 and held it in 14 quarters. The position peaked at $1K in Q2 2022. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 20 Chemours shares in Q2 2025, an estimated $271.
  • Carolinas Wealth Consulting first reported a position in Chemours in Q4 2021 and held it in 14 quarters.
  • Carolinas Wealth Consulting's Chemours position peaked at $1K in Q2 2022.
  • 434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.